International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Sleep-disordered breathing

Symposium
Chairs: Stylianos Orfanos (Athens, Greece), Wilfried De Backer (Edegem (Antwerp), Belgium)
Aims: To provide up-to-date insights into sleep and obstructive sleep apnoea syndrome (OSAS) in the intensive care unit (ICU); ventilatory treatment in obesity hypoventilation syndrome (OHS) (the results of a recent randomised controlled trial will be presented); perioperative sleep disturbances; and sleep-related disorders in the paediatric setting that require evaluation and ventilatory treatment.
Target audience: Pulmonologists, intensivists, sleep physicians respiratory therapists, paediatricians, and surgeons.

Download all media

OSAS in the perioperative period Cesare Gregoretti (Turin, Italy)
Efficacy of CPAP and NIV in long term treatment of OHS: the results of the Spanish multicentre randomised trial "Pickwicks" Juan Fernando Masa Jiménez (Cáceres, Spain)
CPAP/NIV in paediatric patients with sleep disturbances Brigitte Fauroux (Paris, France)